Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (10) , 1259-1267
- https://doi.org/10.1038/modpathol.3800176
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinomaCancer, 2002
- Alterations of expression of Rb, p16INK4A and cyclin D1 in non-small cell lung carcinoma and their clinical significanceThe Journal of Pathology, 1999
- Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung TumorsAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998
- Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpressionCancer, 1997
- Cancer Cell CyclesScience, 1996
- Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerBritish Journal of Cancer, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- Mitosis in transitionCell, 1994
- Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.Molecular and Cellular Biology, 1994